“Molecular Docking Study of Luteolin and its Derivatives for Identifying Potential ER-α Inhibitors in Breast Cancer” (2025) Journal of Pharmaceutical and Sciences, 8(3), pp. 2127–2142. doi:10.36490/journal-jps.com.v8i3.1022.